发明名称 |
Treatment of diabetes mellitus by long–acting formulations of insulins |
摘要 |
<p>The application relates to an aqueous pharmaceutical formulation for use in the treatment of Type I or Type II Diabetes Mellitus, wherein the treatment reduces the risk of nocturnal hypoglycemia, said formulation comprising 200–1000 U/mL [equimolar to 200–1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine.</p> |
申请公布号 |
AU2014247167(A1) |
申请公布日期 |
2015.10.22 |
申请号 |
AU20140247167 |
申请日期 |
2014.04.01 |
申请人 |
SANOFI |
发明人 |
MUHLEN-BARTMER, ISABEL;ZIEMEN, MONIKA |
分类号 |
A61K38/28;A61K9/00;A61P3/10 |
主分类号 |
A61K38/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|